🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the efficacy of the implementation...
Status
Terminated
Location
Centre Jean Perrin
Start Date
2011-09-06
Trial ID
NCT01847599
RATIONALE: Drugs used in chemotherapy, such as capecitabine, work in differ...
Status
Completed
Location
Abramson Cancer Center of The University of Pennsylvania
Start Date
2009-10
Trial ID
NCT01044433
Treatments Being Tested
This study will compare the anti-tumor efficacy of apricoxib and lapatinib/...
Status
Terminated
Location
Arizona Clinical Research Center
Start Date
2008-04
Trial ID
NCT00657137
Treatments Being Tested
RATIONALE: Lapatinib ditosylate may stop the growth of tumor cells by block...
Status
Completed
Location
Centre Leon Berard
Start Date
2009-04
Trial ID
NCT00967031
Treatments Being Tested
This is a Phase III, randomized, multicenter, international, 2-arm, open-la...
Status
Completed
Location
Multiple Locations
Start Date
2009-02
Trial ID
NCT00829166
Treatments Being Tested
The purpose of this study is to demonstrate that SYD985 \[(vic-)trastuzumab...
Status
Completed
Location
Southern Cancer Center
Start Date
2017-12-15
Trial ID
NCT03262935
Treatments Being Tested
Combining Erb inhibitors, such lapatinib, and TS inhibitors, such as capeci...
Status
Terminated
Location
CHARITÉ CAMPUS, VIRCHOW-KLINIKUM, UNIVERSITÄTSMEDIZIN BERLIN, Centrum 14, Medizinische Klinik mit Schwerpunkt Hämatologie und Onkologie
Start Date
2010-06
Trial ID
NCT01145404
Treatments Being Tested
This is a randomized controlled trial of HER-2 positive breast cancer patie...
Status
Unknown
Location
PUMCH
Start Date
2017-03-01
Trial ID
NCT03085368
Treatments Being Tested
This study is an open-label, dose-escalation study of MM-111 with five diff...
Status
Completed
Location
Rocky Mountain Cancer Centers
Start Date
2011-01
Trial ID
NCT01304784
The purpose of this study is to estimate the clinical benefit of lapatinib ...
Status
Withdrawn
Location
Charite Campus Mitte II. Medizinische Klinik Hämatologie und Onkologie
Start Date
2013-09
Trial ID
NCT01985893
Treatments Being Tested